EyePoint Pharmaceuticals, Inc.’s US$230 Million Public Offering Of Common Stock

Hogan Lovells advised EyePoint Pharmaceuticals on its offering.EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) closed its US$230 million follow-on public offering of 13,529,411 shares of common stock at…